National Institutes of Health (NIH): Intramural Research Program (IRP)’s Post

Wondering what exactly cancer is? Watch this insightful video from a medical oncologist for a clear explanation. Knowledge is power! #CancerEducation

🔬 #Immunotherapy #CancerResearch | This article by Cancer Research UK (CRUK) explores how tracking the co-evolution of tumors and the immune system can enhance cancer treatments. Understanding the dynamic interaction between cancer cells and the immune system is crucial for developing more effective therapies. This article highlights the importance of studying these interactions over time and space to target cancer cells at their most vulnerable 🔽

What is Cancer? Dr. Amit Sarma, MD, oncologist at Virginia Cancer Specialists - sheds light on the complexities of cancer and its spread within the human body. From the very beginnings of cellular replication to the potential consequences of DNA mutations, understand the essence of this disease and its impact. Don't miss out on this enlightening exploration into the mechanisms of cancer. Watch now to broaden your knowledge! #cancerawareness #spreadofcancer #oncologyinsights

I’m delighted to share that Cancer Grand Challenges have funded 5 new cancer research teams.   Cancer Grand Challenges is a global funding initiative (co-founded by Cancer Research UK (CRUK) and the National Cancer Institute (NCI) in the US) to bring together a worldwide community of world-class research teams in pursuit of tackling some of the biggest questions in cancer research. The CGC teams are spread across 12 different countries, over 45 institutions and involve 67 investigators.   The five teams – KOODAC, MATCHMAKERS, PROSPECT, PROTECT, and SAMBAI – will drive progress against four challenges – tumours in children and young people, T-cell receptors, cancer inequities, and early-onset cancers.   #CancerGrandChallenges #CancerResearch https://cruk.ink/48HyGgg

Exciting new commentary by our Conquering KRAS in Pancreatic Cancer TeamLab members, Dr. Anirban Maitra from MD Anderson Cancer Center and Dr. Andrew J. Aguirre from Dana-Farber Cancer Institute is now published in Cancer Research, an American Association for Cancer Research journal. The commentary highlights that advancements in KRAS inhibition for pancreatic cancer are driven by strong collaborations!    “The current 'revolution' in KRAS inhibition was made possible by partnerships between oncologists and pathologists, cancer biologists and chemists, and academia and biotech—a spirit of collaboration motivated by the importance of the problem at hand."   Read more here: https://lnkd.in/epwWYw-6   #RadicalCollaboration #CancerResearch 

🩻 Game-changing development in lung cancer research – new project names SPACETIME lead by Amsterdam’s UMC have received €12 million funding for a potential cure for lung cancer. ❤️🩹 Lung cancer is the leading cause of cancer death with 1.2 million deaths reported annually worldwide – with 14,500 people in the Netherlands being diagnosed each year. 💉 But what will the project specifically be looking at? The research will be focused on the connection of cancer cells, immune cells, and supporting cells found in tumours. 📊 Researchers will link all the collected data using computer models to uncover underlying patterns then test these patterns for predictive value in certain treatments, helping doctors better advise patients on the most suitable treatment plan. 🔗 Discover the details of the SPACETIME project here: https://lnkd.in/eeEK2ajb #MedicalResearchAMS #HealthcareInnovation #CancerResearchAMS #HealthTech

Dr. Edjah Nduom, a neurosurgical oncologist at Emory's Winship Cancer Institute, has been appointed by President Biden to the National Cancer Advisory Board. Dr. Nduom, the only Georgian on the board, will help shape national cancer research policy and advance the “Cancer Moonshot” initiative aiming to halve U.S. cancer deaths in 25 years. 🧠 Learn more about Dr. Nduom's groundbreaking work and his vision for the future of cancer treatment. Read the full article 👉 https://bit.ly/3KEZNip #CancerResearch #CancerAwareness #EmoryUniversity #BrainCancerResearch

The IU Simon Comprehensive Cancer Center is taking on lung cancer from every angle. The Tom and Julie Wood Center for Lung Cancer Research was established in March 2024 with a $20 million gift from Julie Wood. The gift honors her late husband, Tom Wood, the well-known Indianapolis auto executive who died of lung cancer in 2010. The newly established center will expand efforts in basic science research to understand the complexities of lung cancer at a cellular level, guide the development of innovative lung cancer drugs, support early-phase clinical trials for IU-developed treatments, and expand the lung cancer precision genomics program. Learn more: https://ow.ly/hXYh50QWABw. #ResearchCuresCancer | Indiana University School of Medicine | Indiana University Research

🔬 A recent study from UCLA's Jonsson Comprehensive Cancer Center reveals promising results for using Manuka honey to help combat breast cancer. The research, conducted on mice, focused on estrogen receptor-positive breast cancer cells which comprise 70-80% of all cases. It found that Manuka honey could slow tumor growth by 84% without harming healthy cells. The research suggests that Manuka honey could complement existing treatments, potentially offering a natural, less toxic option for patients. While more research is needed to test its effectiveness in human clinical trials, these findings open up exciting possibilities for integrating Manuka honey into cancer care. Read more: https://lnkd.in/gdsREyDP #ManukaHoney #BreastCancerResearch #NaturalTherapies #CancerTreatment

There has been a groundbreaking discovery in the fight against brain cancer using Zika virus. Recent studies have shown that a live-attenuated Zika virus can effectively target and eliminate glioblastoma (GBM) cells, with a 65% to 90% reduction in cancer cell population. The virus has the potential to be a selective treatment option for brain cancer, as it exhibits a reduced capacity to affect healthy cells. This is a promising advancement in oncological research, marking the first detailed molecular analysis of the Zika virus's ability to fight cancer cells while sparing healthy tissue. #BrainCancer #MedicalInnovation #ZikaVirusResearch